Compound ID | 13
Class: Antimicrobial peptide
Spectrum of activity: | Gram-positive |
Details of activity: | S. aureus skin infections |
Institute where first reported: | Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia |
Year first mentioned: | 2015 |
Highest developmental phase: | Preclinical |
Development status: | Experimental |
External links: | |
Citations: |
|